Arbutus Biopharma (ABUS) Cash & Equivalents (2010 - 2026)
Arbutus Biopharma (ABUS) posted Cash & Equivalents of $19.17 million for Q2 2026, down 48.8% from $37.41 million a year earlier and down 19.1% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Arbutus Biopharma's Cash & Equivalents came in at $18.01 million, down 50.4% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -19.2% (FY2020 to FY2025).
- In prior years, Arbutus Biopharma's Cash & Equivalents was $36.33 million in FY2024 (+38.2%), $26.29 million in FY2023 (-14.6%), $30.78 million in FY2022 (-71.8%) and $109.28 million in FY2021 (+109.1%).
- Quarterly Cash & Equivalents has run from a low of $17.53 million in Q3 2023 to a high of $109.28 million in Q4 2021 over five years.
- On a year-over-year basis, Cash & Equivalents has declined in each of the last six quarters, with an average decline of 12.4% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q2 2024, with growth of 130.9%; the weakest was Q4 2022, with a decline of 71.8%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $23.71 million (Q1 2026), $18.01 million (Q4 2025) and $22.41 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Arbutus Biopharma | 944.69 Mn | 571.67 Mn | - | 19.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.17 Mn |
| Mar 31, 2026 | 23.71 Mn |
| Dec 31, 2025 | 18.01 Mn |
| Sep 30, 2025 | 22.41 Mn |
| Jun 30, 2025 | 37.41 Mn |
| Mar 31, 2025 | 37.08 Mn |
| Dec 31, 2024 | 36.33 Mn |
| Sep 30, 2024 | 31.85 Mn |
| Jun 30, 2024 | 62.79 Mn |
| Mar 31, 2024 | 43.10 Mn |
| Dec 31, 2023 | 26.29 Mn |
| Sep 30, 2023 | 17.53 Mn |
| Jun 30, 2023 | 27.20 Mn |
| Mar 31, 2023 | 40.57 Mn |
| Dec 31, 2022 | 30.78 Mn |
| Sep 30, 2022 | 24.00 Mn |
| Jun 30, 2022 | 47.32 Mn |
| Mar 31, 2022 | 81.33 Mn |
| Dec 31, 2021 | 109.28 Mn |
| Sep 30, 2021 | 77.88 Mn |
API Access
Arbutus Biopharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();